Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Increased risk for second primary rectal cancer after pelvic radiation therapy.

Rombouts AJM, Hugen N, Elferink MAG, Poortmans PMP, Nagtegaal ID, de Wilt JHW.

Eur J Cancer. 2020 Jan;124:142-151. doi: 10.1016/j.ejca.2019.10.022. Epub 2019 Nov 22.

PMID:
31765989
2.

Incidence of second tumors after treatment with or without radiation for rectal cancer.

Rombouts AJM, Hugen N, Elferink MAG, Feuth T, Poortmans PMP, Nagtegaal ID, de Wilt JHW.

Ann Oncol. 2017 Mar 1;28(3):535-540. doi: 10.1093/annonc/mdw661.

3.

Does pelvic radiation increase rectal cancer incidence? - A systematic review and meta-analysis.

Rombouts AJM, Hugen N, van Beek JJP, Poortmans PMP, de Wilt JHW, Nagtegaal ID.

Cancer Treat Rev. 2018 Jul;68:136-144. doi: 10.1016/j.ctrv.2018.05.008. Epub 2018 Jun 26. Review.

4.

External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.

Eur Urol. 2019 Feb;75(2):319-328. doi: 10.1016/j.eururo.2018.09.034. Epub 2018 Oct 4.

PMID:
30293908
5.

The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.

Krasnow RE, Rodríguez D, Nagle RT, Mossanen M, Kibel AS, Chang SL.

Urol Oncol. 2018 Nov;36(11):500.e11-500.e19. doi: 10.1016/j.urolonc.2018.06.007. Epub 2018 Sep 21.

PMID:
30249519
6.

Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.

Warschkow R, Güller U, Cerny T, Schmied BM, Plasswilm L, Putora PM.

Radiother Oncol. 2017 Apr;123(1):139-146. doi: 10.1016/j.radonc.2017.02.007. Epub 2017 Mar 9.

PMID:
28285840
7.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, Lal S, Henson CC, Andreyev HJN.

Cochrane Database Syst Rev. 2018 Jan 23;1:CD012529. doi: 10.1002/14651858.CD012529.pub2. Review.

8.

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study.

Kang YM, Chao TF, Wang TH, Hu YW.

Cancer Med. 2019 Jul;8(8):3639-3647. doi: 10.1002/cam4.2030. Epub 2019 May 18.

9.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.

Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A.

Lancet Oncol. 2019 Feb;20(2):267-281. doi: 10.1016/S1470-2045(18)30757-5. Epub 2018 Dec 19.

PMID:
30579763
10.

Total pelvic exenteration for primary and recurrent malignancies.

Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH.

World J Surg. 2009 Jul;33(7):1502-8. doi: 10.1007/s00268-009-0066-7.

11.

Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.

Blanchard P, Faivre L, Lesaunier F, Salem N, Mesgouez-Nebout N, Deniau-Alexandre E, Rolland F, Ferrero JM, Houédé N, Mourey L, Théodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Davin JL, Habibian M, Culine S, Laplanche A, Fizazi K.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):85-92. doi: 10.1016/j.ijrobp.2015.09.020. Epub 2015 Sep 25.

PMID:
26576711
12.

Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.

Hamilton SN, Tyldesley S, Hamm J, Jiang WN, Keyes M, Pickles T, Lapointe V, Kahnamelli A, McKenzie M, Miller S, Morris WJ.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):934-41. doi: 10.1016/j.ijrobp.2014.07.032. Epub 2014 Sep 17.

PMID:
25240272
13.

Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.

Martling A, Smedby KE, Birgisson H, Olsson H, Granath F, Ekbom A, Glimelius B.

Br J Surg. 2017 Feb;104(3):278-287. doi: 10.1002/bjs.10327. Epub 2016 Nov 1.

PMID:
27802358
14.

The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.

Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM.

Can J Urol. 2017 Feb;24(1):8656-8662.

PMID:
28263132
15.

Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer.

Vulto JC, Lybeert ML, Louwman MW, Poortmans PM, Coebergh JW.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):464-71. doi: 10.1016/j.ijrobp.2008.08.074. Epub 2009 Mar 14.

PMID:
19289268
16.

Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.

Neugut AI, Ahsan H, Robinson E, Ennis RD.

Cancer. 1997 Apr 15;79(8):1600-4.

PMID:
9118045
17.

Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.

Lee YC, Hsieh CC, Li CY, Chuang JP, Lee JC.

World J Surg. 2016 Apr;40(4):895-905. doi: 10.1007/s00268-015-3324-x. Review.

PMID:
26711638
18.

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.

Wiltink LM, Nout RA, Fiocco M, Meershoek-Klein Kranenbarg E, Jürgenliemk-Schulz IM, Jobsen JJ, Nagtegaal ID, Rutten HJ, van de Velde CJ, Creutzberg CL, Marijnen CA.

J Clin Oncol. 2015 May 20;33(15):1640-6. doi: 10.1200/JCO.2014.58.6693. Epub 2014 Dec 22.

PMID:
25534376
19.

A population-based analysis of second primary cancers after irradiation for rectal cancer.

Kendal WS, Nicholas G.

Am J Clin Oncol. 2007 Aug;30(4):333-9.

PMID:
17762431
20.

Supplemental Content

Support Center